Drug repurposing: progress, challenges and recommendations

被引：0

作者：

Sudeep Pushpakom

Francesco Iorio

Patrick A. Eyers

K. Jane Escott

Shirley Hopper

Andrew Wells

Andrew Doig

Tim Guilliams

Joanna Latimer

Christine McNamee

Alan Norris

Philippe Sanseau

David Cavalla

Munir Pirmohamed

机构：

[1] MRC Centre for Drug Safety Science,Department of Molecular and Clinical Pharmacology

[2] University of Liverpool,Department of Biochemistry

[3] Wellcome Sanger Institute,Licensing Division

[4] Institute of Integrative Biology,Manchester Institute of Biotechnology and Department of Chemistry

[5] University of Liverpool,undefined

[6] Emerging Innovations Unit,undefined

[7] Scientific Partnering and Alliances,undefined

[8] IMED Biotech Unit,undefined

[9] Medicines and Healthcare Products Regulatory Agency (MHRA),undefined

[10] Harrison Goddard Foote,undefined

[11] Patent and Trademark Attorneys,undefined

[12] Faculty of Science and Engineering,undefined

[13] The University of Manchester,undefined

[14] Healx Ltd.,undefined

[15] St John's Innovation Centre,undefined

[16] Medical Research Council,undefined

[17] Medicines Research Centre,undefined

[18] Target Sciences,undefined

[19] GlaxoSmithKline R&D,undefined

[20] Numedicus Ltd,undefined

来源：

Nature Reviews Drug Discovery | 2019年 / 18卷 / 1期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Drug repurposing — a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication — has the potential for greater success rates and reduced costs compared with developing entirely new drugs. Pirmohamed and colleagues present approaches used for drug repurposing, discuss the challenges faced by the repurposing community and recommend innovative ways by which these challenges could be addressed.

引用

页码：41 / 58

页数：17

共 50 条

[21] Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
Porta, Exequiel O. J.
Kalesh, Karunakaran
Steel, Patrick G.
FRONTIERS IN PHARMACOLOGY, 2023, 14
[22] Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates
Southan, Christopher
Williams, Anthony J.
Ekins, Sean
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[23] Transdermal drug delivery: progress and challenges
Ita, K. B.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2014, 24 (03) : 245 - 250
[24] Microneedles in Drug Delivery: Progress and Challenges
Avcil, Muhammet
Celik, Ayhan
MICROMACHINES, 2021, 12 (11)
[25] Drug policy in China: progress and challenges
Yang, Mei
Zhou, Liang
Hao, Wei
Xiao, Shui-Yuan
LANCET, 2014, 383 (9916): : 509 - 509
[26] Progress and challenges in intravesical drug delivery
Banerjee, Arpita
Lee, Dongtak
Jiang, Christopher
Wang, Rong
Kutulakos, Zoe Bogusia
Lee, Sohyung
Gao, Jingjing
Joshi, Nitin
EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (01) : 111 - 129
[27] Hydrogels in drug delivery: Progress and challenges
Hoare, Todd R.
Kohane, Daniel S.
POLYMER, 2008, 49 (08) : 1993 - 2007
[28] Drug Repurposing: Research Progress of Niclosamide and Its Derivatives on Antibacterial Activity
Liu, Zhihong
Liang, Xiaofang
Zhang, Yu
Deng, Wenbo
Wang, Yulin
Lu, Zhangping
Liu, Qianqian
Wei, Lianhua
INFECTION AND DRUG RESISTANCE, 2024, 17 : 4539 - 4556
[29] Pediatric drug development: existing challenges and recommendations
Kaguelidou, Florentia
Ouedraogo, Maria
Treluyer, Jean-Marc
Le Jeunne, Claire
Annereau, Maxime
Blanc, Patricia
Bureau, Serge
Ducassou, Stephane
Fiquet, Beatrice
Flamein, Florence
Gaillard, Segolene
Hankard, Regis
Laugel, Vincent
Laurent, Corinne
Levy, Corinne
Marquet, Thierry
Polak, Michel
Portefaix, Aurelie
Vassal, Gilles
THERAPIE, 2023, 78 (01): : 95 - 104
[30] Navigating Metabolic Challenges in Ovarian Cancer: Insights and Innovations in Drug Repurposing
Mikhael, Sara
Daoud, Georges
CANCER MEDICINE, 2025, 14 (04):

← 1 2 3 4 5 →